ORAL NUTRITION SUPPLEMENTS’ IMPACT ON HOSPITAL OUTCOMES IN THE CONTEXT OF THE AFFORDABLE CARE ACT AND NEW MEDICARE REIMBURSEMENT POLICIES
In 2014, a retrospective health economic outcome study by Lakdawalla showed that ONS use was associated with reductions in probability of 30-day readmission by 12.0% in acute myocardial infarction (AMI) and 10.1% in congestive heart failure (CHF). Length of stay (LOS) decreases of 10.9% in AMI, 14.2% in CHF, and 8.5% in pneumonia (PNA) were associated with ONS, as were decreases in episode costs in AMI, CHF and PNA of 5.1%, 7.8% and 10.6%, respectively. The effect on LOS and episode cost was greatest for the Any Diagnosis population, with decreases of 16.0% and 15.8%, respectively.
Stay Connected